Arlington Trust’s Mesoblast MESO Stock Holding History

Arlington Trust’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-86	Closed	-$189	–	731
2023 Q4	$189	Buy	+86	New	+$205	﹤0.01%	895

Other funds holding MESO

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

SXL

Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return

PWM

Prosperity Wealth Management San Ramon, California $300M AUM 28.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Arlington Trust's MESO Position: Q1 2024 in Review

Arlington Trust sold out of Mesoblast (MESO) in Q1 2024, closing a stake of 86 shares — an estimated $189 sold.

Arlington Trust first reported a position in MESO in Q4 2023 and held it in 1 quarter. The position peaked at $189 in Q4 2023. 26 funds tracked by Wall St. Rank hold MESO as of Q1 2024.

Arlington Trust reported no remaining Mesoblast position as of Q1 2024 after selling out during the quarter.
Arlington Trust sold 86 Mesoblast shares in Q1 2024, an estimated $189.
Arlington Trust first reported a position in Mesoblast in Q4 2023 and held it in 1 quarter.
Arlington Trust's Mesoblast position peaked at $189 in Q4 2023.
26 funds tracked by Wall St. Rank held Mesoblast as of Q1 2024.

Based on Arlington Trust's 13F filing for Q1 2024, filed 16 Apr 2024.